14 results on '"Prakoso D"'
Search Results
2. Cardiac Remodelling and Inflammation Associated with Diabetic Cardiomyopathy is Mitigated by Phosphoinositide 3-Kinase P110α Gene Delivery.
3. Using Gene Delivery to Target Cardiac O-GlcNAc Protein Modifications in the Diabetic Heart: Impact on Left Ventricular (LV) Function.
4. Cardiac-Specific Insulin-like Growth Factor-1 Receptor (IGF-1R) Expression Attenuates Upregulation of Left Ventricular Hexosamine Biosynthesis (HBP) Flux and Oxidative Stress in Diabetic Mouse Myocardium.
5. Phosphoinositide 3-Kinase p110alpha Gene Therapy Rescues Diabetic Cardiomyopathy in a Type 2 Diabetic Model.
6. Phosphoinositide 3 kinase p110a (rAAV6-caPI3K) gene therapy attenuates diabetic cardiomyopathy in mice.
7. Characterising the Myocardial Mitochondria Phenotype in a Murine Model of Diabetic Cardiomyopathy.
8. Characterising the Myocardial Mitochondria Phenotype in a Murine Model of Diabetic Cardiomyopathy.
9. Defining the Characteristics of a More Clinically Relevant Mouse Model of Type-2 Diabetes (T2D)-Induced Cardiomyopathy.
10. Mapping the Cellular Landscape of the Diabetic Heart.
11. Mapping the Cellular Landscape of the Diabetic Heart.
12. 040 Investigating the Role of Mitochondria-Targeted Antioxidant, MitoQ, in Cardiomyocytes Exposed to High Glucose.
13. 040 Investigating the Role of Mitochondria-Targeted Antioxidant, MitoQ, in Cardiomyocytes Exposed to High Glucose.
14. Progression of Markers Contributing to Cardiomyopathy in a Mouse Model of Type 1 Diabetes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.